Clinical Trials Directory

Trials / Conditions / Fallopian Tube High Grade Serous Adenocarcinoma

Fallopian Tube High Grade Serous Adenocarcinoma

9 registered clinical trials studyying Fallopian Tube High Grade Serous Adenocarcinoma — 1 currently recruiting.

StatusTrialSponsorPhase
RecruitingTesting Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
NCT06580314
NRG OncologyPhase 3
Active Not RecruitingTesting the Addition of Ipatasertib to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) for Stage
NCT05276973
National Cancer Institute (NCI)Phase 1
Active Not RecruitingTesting the Addition of an Anti-cancer Drug, Elimusertib (BAY 1895344) ATR Inhibitor, to the Chemotherapy Trea
NCT04616534
National Cancer Institute (NCI)Phase 1
Active Not RecruitingA Study Combining the Peposertib (M3814) Pill With Standard Chemotherapy in Patients With Ovarian Cancer With
NCT04092270
National Cancer Institute (NCI)Phase 1
Active Not RecruitingTesting the Addition of an Immunotherapy Drug, Tremelimumab, to the PARP Inhibition Drug, Olaparib, for Recurr
NCT04034927
National Cancer Institute (NCI)Phase 2
Active Not RecruitingBevacizumab and Anetumab Ravtansine or Paclitaxel in Treating Patients With Refractory Ovarian, Fallopian Tube
NCT03587311
National Cancer Institute (NCI)Phase 2
Active Not RecruitingPegylated Liposomal Doxorubicin Hydrochloride With Atezolizumab and/or Bevacizumab in Treating Patients With R
NCT02839707
National Cancer Institute (NCI)Phase 2 / Phase 3
CompletedRuxolitinib Phosphate, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV Epithelial Ovarian,
NCT02713386
NRG OncologyPhase 1 / Phase 2
Active Not RecruitingAdavosertib Before Surgery in Treating Patients With Advanced High Grade Ovarian, Fallopian Tube, or Primary P
NCT02659241
M.D. Anderson Cancer CenterEARLY_Phase 1